Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Elicio Therapeutics, Inc. (ELTX) had Weighted-Average Shares Outstanding (Diluted) of 15.31M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.72M |
|
-- |
|
-- |
|
$8.84M |
|
$-8.84M |
|
$1.12M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-8.84M |
|
$-8.37M |
|
15.31M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
15.31M |
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$19.31M |
|
$0.29M |
|
$6.55M |
|
$25.86M |
|
$8.11M |
|
$9.41M |
|
$16.12M |
|
$24.23M |
|
$1.64M |
|
$1.64M |
|
$1.64M |
|
17.80M |
|
| Cash Flow Statement Financials | |
$-36.95M |
|
$-0.02M |
|
$36.70M |
|
$19.49M |
|
$19.27M |
|
$-0.23M |
|
$2.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
0.85 |
|
5.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-36.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-471.76% |
|
-471.76% |
|
-29.84% |
|
-69.89% |
|
$0.09 |
|
$-2.41 |
|
$-2.41 |
|